Among primary brain tumors, activating BRAF point mutations are found frequently in pleomorphic xanthoastrocytoma (60 – 70%) and ganglioglioma (~ 20%) and less frequently in pilocytic astrocytomas [3]. The gene discussed is BRAF; the disease is brain neoplasm.